Machine Learning

A new report reveals a massive surge in ransomware attacks on vehicles, with AI creating new dangers for drivers and global supply chains. Is your car safe?

Motive's new AI automates driver records and compliance, offering a powerful shield against millions in fines and crippling administrative paperwork.

AVEO Oncology's ficlatuzumab advances in a pivotal Phase 3 trial, offering new hope for patients with a difficult-to-treat form of head and neck cancer.

A Fort Worth dentist's new non-surgical therapy aims to reshape child development by addressing the hidden link between airway health, sleep, and behavior.

A new AI platform promises to shrink insurance underwriting from days to minutes, but its rise sparks critical questions about bias and the future of the industry.

Automotive giant NAPA is deploying over 100 AI robots from Brightpick in a landmark deal set to accelerate its supply chain and challenge industry rivals.

New data on Spyre Therapeutics' SPY003 suggests a twice-yearly shot for IBD is possible, part of a broader strategy to challenge market giants.

With supply chain attacks surging, Manifest hires a new revenue chief to capitalize on the critical demand for AI and software transparency.

Creative Realities repurchased 1.7M stock warrants for just $200,000, a strategic move to prevent dilution and pave the way for ambitious growth.

As RSAC celebrates 35 years, its 2026 lineup featuring Jacinda Ardern and Hugh Jackman signals cybersecurity's pivotal mainstream moment.

A new US-designed and assembled O-RAN radio marks a major step in America's push for a secure, domestic 5G supply chain, fueled by NTIA funding.

Despite a revenue dip and leasing decline from a partner bankruptcy, PROG Holdings shows resilience with strong growth in its BNPL arm and a major acquisition.

Unnatural Products inks a major deal with Novartis, using its AI-driven macrocycle technology to develop novel cardiovascular drugs for intractable diseases.

A new collaboration aims to solve the pesticide resistance crisis by mass-producing potent, eco-friendly peptide solutions at grower-friendly costs.

Bausch + Lomb beats Q4 revenue forecasts, propelled by its blockbuster dry eye drug MIEBO, and issues a confident financial outlook for 2026.

Upwork announces a new $300M share buyback, signaling deep confidence in its AI strategy and financial health as it aims to redefine the future of work.

A new AI-native system, Isaac PracticeOS, promises to replace up to ten dental software tools, automating claims, scheduling, and patient communications.

As AI risks grow, companies like Cycore are racing to offer unified compliance solutions for a complex and costly web of new global regulations.

ActiveCampaign is shaking up the martech world with a 30-day results guarantee, promising instant AI-driven outcomes or a full refund.

A new biotech emerges with massive funding and a next-gen 'shuttle' to deliver safer, more effective Alzheimer's therapies directly to the brain.